Van Dam J, Rice T W, Catalano M F, Kirby T, Sivak M V
Department of Gastroenterology, Cleveland Clinic Foundation, Ohio.
Cancer. 1993 May 15;71(10):2910-7. doi: 10.1002/1097-0142(19930515)71:10<2910::aid-cncr2820711005>3.0.co;2-l.
Endosonography is very accurate for the preoperative staging of esophageal carcinoma. Approximately 20-38% of patients with esophageal carcinoma present with high-grade malignant strictures that preclude passage of the dedicated echoendoscope. In patients with such strictures, endosonographic staging of esophageal tumors may be performed after aggressive esophageal dilatation. However, aggressive dilatation and passage of the echoendoscope in patients with high-grade malignant strictures is not without risk. A detailed assessment of the tumor stage in patients presenting with high-grade malignant stenoses has not been previously reported to the authors' knowledge.
Seventy-nine patients with esophageal carcinoma were staged preoperatively using endosonography. The results of preoperative staging were compared with the pathologic stage of the esophagectomy specimen when available or the surgical stage (detection of adjacent organ involvement [Stage T4] or metastatic disease [Stage M1] at the time of surgery).
Twenty-one patients (26.6%) presented with high-grade malignant strictures precluding endosonographic examination without prior esophageal dilatation. Nineteen of the 21 patients (91%) with high-grade malignant stricture had Stage III or IV disease by histopathologic examination of the surgical specimen. Five of these 21 patients (24%) sustained an esophageal perforation as a result of either wire-guided dilatation, or as a direct consequence of the endosonographic staging procedure. The discovery of metastatic lymph nodes proximal to the stricture resulted in successful staging (assessment of depth of tumor penetration and lymph node involvement) in only 2 of these 21 patients before esophageal dilatation (incomplete staging). Staging of the proximal aspect of the tumor was obtained in the remaining 19 patients before dilatation; however, the accuracy for such incomplete staging was only 33%.
The majority of patients with esophageal carcinoma presenting with high-grade malignant strictures precluding endoscope passage without prior dilatation have a relatively advanced stage of disease (Stage III or IV) compared with those patients presenting with less severe stenoses. There is a significant risk for esophageal perforation (24%) when patients with high-grade malignant esophageal strictures undergo preoperative staging using endosonography. Patients with high-grade malignant strictures, therefore, present a relative contraindication to endosonography using the dedicated echoendoscope.
内镜超声检查对食管癌术前分期非常准确。约20% - 38%的食管癌患者存在高度恶性狭窄,这使得专用超声内镜无法通过。对于此类狭窄患者,可在积极进行食管扩张后进行食管肿瘤的内镜超声分期。然而,在高度恶性狭窄患者中进行积极扩张及超声内镜通过并非毫无风险。据作者所知,此前尚无关于高度恶性狭窄患者肿瘤分期详细评估的报道。
对79例食管癌患者术前行内镜超声检查分期。将术前分期结果与食管切除标本的病理分期(如有)或手术分期(手术时发现邻近器官受累[T4期]或转移性疾病[M1期])进行比较。
21例患者(26.6%)存在高度恶性狭窄,在未预先进行食管扩张的情况下无法进行内镜超声检查。21例高度恶性狭窄患者中,19例(91%)手术标本的组织病理学检查显示为Ⅲ期或Ⅳ期疾病。这21例患者中有5例(24%)因导丝引导扩张或内镜超声分期操作直接导致食管穿孔。在这21例患者中,仅2例在食管扩张前通过发现狭窄近端的转移性淋巴结成功进行了分期(评估肿瘤浸润深度和淋巴结受累情况)(分期不完整)。其余19例患者在扩张前获得了肿瘤近端的分期;然而,这种不完整分期的准确性仅为33%。
与狭窄程度较轻的患者相比,大多数存在高度恶性狭窄且未预先扩张就无法通过内镜的食管癌患者疾病分期相对较晚(Ⅲ期或Ⅳ期)。高度恶性食管狭窄患者术前行内镜超声检查分期时,食管穿孔风险显著(24%)。因此,高度恶性狭窄患者相对禁忌使用专用超声内镜进行内镜超声检查。